CLBS
$Caladrius Biosciences (CLBS.US)$ $Caladrius生物科学 Caladrius Biosciences (NASDAQ:CLBS): Q2 GAAP EPS of -$0.10 beats by $0.04.
Revenue of $43.29M (+138.1% Y/Y)
Revenue of $43.29M (+138.1% Y/Y)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
